Nitric oxide treatment can be essential in the battle against COVID-19 Kumar Jeetendra | July 27, 2020 Nitric oxide therapy could be critical in the world’s struggle against SARS-CoV-2, the coronavirus which causes COVID-19, according to a review by the George Washington University (GW). Nitric oxide is an antimicrobial and anti inflammatory molecule with key roles in pulmonary arterial role in the context of viral infections as well as other pulmonary diseases. …
Antenatal steroids improve preterm infant endurance in low-asset settings, discovers study Kumar Jeetendra | October 24, 2020 The results of a new clinical trial, published today in the New England Journal of Medicine, show that dexamethasone- a glucocorticoid used to treat many conditions, including rheumatic problems and severe COVID-19- may boost survival of premature babies when given to pregnant women at risk of premature birth in low-resource settings. The WHO ACTION-I trial …
Genomic Data Commons offers the biggest asset in cancer genomics Kumar Jeetendra | February 27, 2021 The National Cancer Institute’s Genomic Data Commons (GDC), launched in 2016 by then-Vice President Joseph Biden and hosted at the University of Chicago, has become one of the largest and most widely used resources in cancer genomics, with over 3.3 petabytes of data from more than 65 jobs and more than 84,000 anonymized patient cases, …
